Article
High‐Level Expression of Recombinant IgG in the Human Cell Line PER.C6
1 Jan 2003
Abstract excerpt
The number of therapeutic monoclonal antibodies in production is expected to rise rapidly in the next few years. As a result, there is much focus on the optimization of antibody expression platforms. Several issues are important including the speed of transition from bench to manufacturing, yield of IgG, and quality (particularly of the glycan structures present on immunoglobulins). We have characterized the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
